BORN Medical Wins 2021 Medical Device Innovation Trend White Paper Award for Frontier Technological Innovation and Files IPO Prospectus

On May 13, 2021, the first day of the 84th China Medical Equipment Fair (CMEF) Spring Edition, the Health Industry Technology Conference was grandly held in Conference Room D1, Hall 4.2 of the National Exhibition and Convention Center. During the conference, the “Research Report on Trends in Health Technology Innovation” was released. Born Medical received the Enterprise Frontier Technological Innovation Award in the 2021 White Paper on Innovation Trends in Medical Devices and was presented with a certificate of honor.

It is reported that the innovative enterprises featured in this white paper on innovation trends were primarily assessed through indicator scoring and expert evaluation, based on awards, literature, and patent data in the medical device industry collected from channels such as national ministries and commissions, medical industry associations, Elsevier’s Scopus database, China National Knowledge Infrastructure (CNKI), and Dawei Innojoy Patent Database.

To scientifically and rationally present the development and innovation status of enterprises in the medical device sector, the evaluation is primarily based on three indicators: the scientific research reputation indicator, namely the Honors and Awards Index (accounting for 40%); the scientific research output indicator, namely publication data (accounting for 30%); and the research translation indicator, namely invention patent data (accounting for 30%).

Born Medical has been committed to becoming a global leader in cranial monitoring technology, with high-tech innovation capabilities and core competitiveness. To achieve this goal, Born Medical has chosen the path of independent research and development since its establishment.

With over two decades of technological accumulation, Bone Medical has been honored with numerous awards, including the Second Prize of the National Science and Technology Progress Award, the First Prize of the Chinese People's Liberation Army Science and Technology Progress Award, and the Third Prize of the Chinese Medical Association Science and Technology Progress Award. The company holds 32 Chinese invention patents, 5 U.S. invention patents, and has published 67 core patent papers and monographs. From 2017 to 2021, it was included in national and provincial key research and development programs a total of 19 times.

In the field of cranial health, BORN-BE, the non-invasive dynamic cerebral edema monitor developed by Born Medical, offers multiple advantages including being non-invasive, continuous, dynamic, and intelligent. It can generate cerebral edema monitoring results in just 40 seconds, partially replacing invasive intracranial pressure (ICP) monitoring, lumbar puncture for pressure measurement, and imaging examinations, thereby providing physicians with more evidence to formulate precise diagnosis and treatment plans for patients with cranial diseases.

BORN-BE utilizes Electrical Impedance Tomography (EIT) technology, which is fundamentally based on the principle of electromagnetic perturbation. Additionally, its user-friendly operation and high portability enable widespread application in settings such as intensive care units (ICUs), general wards, and emergency ambulances.

Born Medical’s stroke solutions include the Ultra-Early Stroke Differentiation Device, the Multimodal Monitoring System for Neurocritical Care, and the Naokang Therapeutic Device. The pediatric neurocritical care solution comprises the Dynamic Cerebral Edema Monitor for Children and the Non-Invasive Blood Oxygen Monitor for Pediatric Agitation. The emergency department solutions include the Non-Invasive Dynamic Pulmonary Edema Monitor and the Non-Invasive Cranial Bioelectrical Impedance Analyzer. Notably, the Ultra-Early Stroke Differentiation Device enables the differentiation between ischemic and hemorrhagic stroke within the critical “golden” 4.5-hour window.